Atlas Trials

Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation

Clinical trial NCT03963154 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03963154
Sponsor
Centre d'Etude des Cellules Souches
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Retinitis Pigmentosa
Start date
2019-08-19
Primary completion
2023-06-22
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.